dsc_3364_grand-opening-korea-drum-playing

Thermo Fisher Scientific Opens New State-of-the Art Clinical Services Facility in Korea

Korea, 9 September, 2016To address the growing global demand for clinical services, Thermo Fisher Scientific, the world leader in serving science, today announced the official opening of its new state-of-the-art GMP facility in South Korea. Strategically located in Seoul, the new site will provide local, regional and global pharmaceutical and biotech companies with a one-stop service for clinical supplies − from cGMP storage, full secondary packaging and labeling, handling and distribution of controlled ambient and cold chain supplies, to clinical site returns and destruction management.

A supportive government, modern infrastructure and an easily accessible patient population are helping this Asian nation become a top location for clinical trial research. Over the past few years, clinical trials have consistently grown in Korea, and with an increased number of core clinical trial sites certified by the Ministry of Food and Drug Safety (MFDS), formerly known as the KFDA, Korea is a leading emerging nation for clinical trial research in Asia. In addition, Korean R&D pharmaceutical companies have demonstrated a strong passion for innovative drug development resulting in a robust industry contributing to therapeutic healthcare developments at local and global levels.

“Asia Pacific continues to be a strategic market and a central contributor to our growth,” said Leon Wyszkowski, Thermo Fisher’s vice president of clinical services for North America and facility network. “In September 2015 we opened a new facility in Singapore to serve as a central hub for our Asia Pacific region, which compliments our clinical services facilities in Beijing and Suzhou, China; Tokyo, Japan and Ahmedabad, India. The opening of this new facility in South Korea is testament to our commitment to continue investing in the region as we build on the expertise of our local teams to strengthen our regional and global presence in the clinical supplies industry.“

kr-building-photo

New cGMP facility with highly experienced local team supporting clinical research in South Korea

Seoul Fast Facts:

Location: East Asia
Population: 51.6 million
Nearest Airport: Gimpo Airport
Distance from Airport(s) to Facility: 2km from Gimpo Airport, 41.8km from Incheon Airport
Fun Fact: Seoul is known for its population density which is about 17,000 people per square kilometer (45,000/square mile)

City:
Seoul
Country:
South Korea
Opened:
2016
Total Capacity:
516 m2
Secondary Packaging Rooms:
2
Warehouse Capacity:
1,1174 m3
Ambient Storage Capacity:
1,043 m3
Refrigerated Storage Capacity (2-8):
130 m3
Frozen Storage Capacity (-20):
1 m3
Environmental Technologies:
Yes
Ancillary Sourcing:
Yes
Secondary Labeling:
Yes
Returns & Destruction:
Yes
free website templates